Changes in plasma levels of gonadotropins in men with hepatic cirrhosis
Rubio Pérez, P.; de Pablos Mateos, I.; Gallardo López, J.; Sánchez Sánchez, M.L.
Revista Clinica Espanola 167(5): 317-320
1982
ISSN/ISBN: 0014-2565 PMID: 6820172 Document Number: 188320
Document emailed within 1 workday
Related Documents
Bellanca, L.; Latteri, M.T.; Latteri, S.; Bajardi, G.; Cassano, T.; Latteri, M. 1984: Influence of L-5-hydroxytryptophan on the secretion of prolactin and on plasma levels of gonadotropins La Clinica Terapeutica 109(5): 429-432O'Keefe, S.J.; Abraham, R.; El-Zayadi, A.; Marshall, W.; Davis, M.; Williams, R. 1981: Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity Gastroenterology 81(6): 1017-1024
Bélisle, S.; Patry, M.; Tétreault, L. 1982: Cimetidine and plasma levels of gonadotropins, prolactin and gonadal steroids in women Canadian Medical Association Journal 127(1): 29-32
Bianchi, G.; Marchesini, G.; Fabbri, A.; Ronchi, M.; Chianese, R.; Grossi, G. 1997: Lipoperoxide plasma levels in patients with liver cirrhosis Hepato-Gastroenterology 44(15): 784-788
Rodríguez Bueno, S.; Ordi Ros, J.; Vilardell Tarrés, M.; Vicente Aranguena, P.; García-Bragado Dalmau, F.; Bosch Gil, J.; Villar Casares, M.; Alijotas Reig, J. 1985: Level of plasma fibronectin in patients with hepatic cirrhosis. its relation to coagulation factor V Medicina Clinica 85(18): 746-748
Wilcox, H.G.; Dunn, G.D.; Schenker, S. 1978: Plasma long chain fatty acids and esterified lipids in cirrhosis and hepatic encephalopathy American Journal of the Medical Sciences 276(3): 293-303
Greco, A.V.; Ghirlanda, G.; Rebuzzi, A.; Altomonte, L.; Manna, R. 1976: Behavior of plasma/insulin, somatropin and NEFA after intravenous administration of tolbutamide in hepatic cirrhosis Minerva Medica 67(54): 3525-3532
Dittrich, S.; de Mattos, A.Alves.; Cheinquer, H.; de Araújo, F.Branco. 2005: Correlation between platelet blood levels and the hepatic venous pressure gradient among patients with cirrhosis Arquivos de Gastroenterologia 42(1): 35-40
Huber, M.; Rössle, M.; Siegerstetter, V.; Ochs, A.; Haag, K.; Kist, M.; Blum, H.E. 2001: Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis Hepato-Gastroenterology 48(38): 541-544
Kanayama, S.; Himeno, S.; Kurokawa, M.; Shinomura, Y.; Kuroshima, T.; Okuno, M.; Tsuji, K.; Higashimoto, Y.; Ikei, N.; Hashimura, E. 1985: Marked prolongation in disappearance half-time of plasma cholecystokinin-octapeptide in patients with hepatic cirrhosis American Journal of Gastroenterology 80(7): 557-560
Marañón, A.; Durán, S.; Sanjose, G.; Romero, E. 1974: Glucose tolerance, insulin secretion, levels of free fatty acids and growth hormone in hepatic cirrhosis Revista Clinica Espanola 132(4): 299-306
Kabadi, U.M.; Premachandra, B.N. 1983: Serum T3 and reverse T3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver dysfunction American Journal of Gastroenterology 78(11): 750-755
Parra Blanco, J.A.; Juanco Pedregal, C.; Silvan Delgado, M. 1995: Changed hepatic vein flow in patients with cirrhosis. A Doppler study of hepatic veins in patients with cirrhosis Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 87(9): 621-623
Goral, V.; Atayan, Y.; Kaplan, A. 2011: The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α? Hepato-Gastroenterology 58: 107-108
Gentile, S.; Loguercio, C.; Russo, F.S.; Coltorti, M. 1991: L-alanine plasma levels after oral loads in non-alcoholic liver cirrhosis: relationship with urea extraformation and ammoniogenesis Italian Journal of Gastroenterology 23(6): 335-340
Kluft, C.; Los, P.; Clemmensen, I.; Brommer, E.J.; Gevers Leuven, J.A.; Boks, A.L.; Vellenga, E. 1989: Quantitation of plasma levels of tetranectin--effects of oral contraceptives, pregnancy, treatment with L-asparaginase and liver cirrhosis Thrombosis and Haemostasis 62(2): 792-796
Campollo, O.; MacGillivray, B.B.; McIntyre, N. 1992: Association of plasma ammonia and GABA levels and the degree of hepatic encephalopathy Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 44(4): 483-490
Saito, N.; Kaji, H.; Hisamura, M.; Murao, M. 1983: Plasma levels of monocarboxylic short chain fatty acids in patients with diabetes mellitus, liver cirrhosis and thyroidal dysfunction Research Communications in Chemical Pathology and Pharmacology 39(2): 337-340
Singh, N.K.; Thapliyal, A.; Jain, A.K.; Chansuria, J.P.; Gupta, J.P.; Srivastava, P.K. 1985: Alterations in plasma and CSF levels of GABA, 5-HT and amino acids in fulminant hepatic failure Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 4(4): 253-255
Fujita, S.; Chiba, M.; Ohta, M.; Kitani, K.; Suzuki, T. 1990: Alteration of plasma sex hormone levels associated with old age and its effect on hepatic drug metabolism in rats Journal of Pharmacology and Experimental Therapeutics 253(1): 369-374